GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Operating Cash Flow per Share

Quest PharmaTech (TSXV:QPT) Operating Cash Flow per Share : C$-0.00 (TTM As of Oct. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Operating Cash Flow per Share?

Quest PharmaTech's operating cash flow per share for the three months ended in Oct. 2023 was C$0.00. Quest PharmaTech's operating cash flow per share for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 57.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 52.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Quest PharmaTech's Operating Cash Flow per Share or its related term are showing as below:

TSXV:QPT' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46.5   Med: -8.3   Max: 71
Current: 57.1

During the past 13 years, Quest PharmaTech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 71.00% per year. The lowest was -46.50% per year. And the median was -8.30% per year.

TSXV:QPT's 3-Year OCF Growth Rate is ranked better than
93.61% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs TSXV:QPT: 57.10

Quest PharmaTech Operating Cash Flow per Share Historical Data

The historical data trend for Quest PharmaTech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Operating Cash Flow per Share Chart

Quest PharmaTech Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.04 -0.02 - -

Quest PharmaTech Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Quest PharmaTech's Operating Cash Flow per Share

For the Biotechnology subindustry, Quest PharmaTech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Price-to-Operating-Cash-Flow falls into.



Quest PharmaTech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Quest PharmaTech's Operating Cash Flow per Share for the fiscal year that ended in Jan. 2023 is calculated as

Operating Cash Flow per Share (A: Jan. 2023 )=Cash Flow from Operations (A: Jan. 2023 )/Shares Outstanding (Diluted Average) (A: Jan. 2023 )
=-0.555/168.395
=-0.00

Quest PharmaTech's Operating Cash Flow per Share for the quarter that ended in Jan. 2023 is calculated as

Operating Cash Flow per Share (Q: Oct. 2023 )=Cash Flow from Operations (Q: Oct. 2023 )/Shares Outstanding (Diluted Average) (Q: Oct. 2023 )
=-0.007/169.129
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest PharmaTech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech (TSXV:QPT) Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines